August 27, 2016 7:02 AM ET

Pharmaceuticals

Company Overview of Lannett Company, Inc.

Executive Profile

Albert R. Paonessa III

Director, Member of Compensation Committee and Member of Strategic Planning Committee, Lannett Company, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
56--

Background

Mr. Albert R. Paonessa, III, also known as Al, served as Chief Operating Officer & Executive Vice President of Distribution Division at Allergan plc (alternative name Actavis, Inc. and Watson Pharmaceuticals, Inc.). Mr. Paonessa served as an Executive Vice President and Chief Operating Officer of Anda Inc. at Andrx Corporation. In this role, which he held for almost 10 years, Paonessa directed Anda's growth to $2 billion in revenues. Mr. Paonessa served as Vice President ...

Corporate Headquarters

13200 Townsend Road
Philadelphia, Pennsylvania 19154

United States

Phone: (215) 333-9000
Fax: --

Board Members Memberships

Director
2015-Present
Director, Member of Compensation Committee and Member of Strategic Planning Committee

Education

BA 1983
Bowling Green State University
BS 1983
Bowling Green State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$1.0M
Arthur S. Przybyl Chief Executive Officer, President and Director
ANI Pharmaceuticals, Inc.
$568.3K
Hari Shanker Bhartia B.TechCo-Chairman, Managing Director, Chairman of Corporate Governance Committee, Member of Finance Committee, Member of Capital Issue Committee, Member of Sustainability & CSR Committee and Member of Fund Raising Committee
Jubilant Life Sciences Limited
--
John Anthony Sedor Chairman, Chief Executive Officer and Member of Nominating Committee
Pernix Therapeutics Holdings, Inc.
--
Allan Oberman Chief Executive Officer and Director
Sagent Pharmaceuticals, Inc.
$244.7K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Lannett Company, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.